Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 71-77

  Sestini, Piersante ^a   Refini, Rosa Metella ^a   Pieroni, Maria Grazia ^a   Vaghi, Adriano ^b   Robuschi, Maria ^c   Bianco, Sebastiane ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Allergen challenge; Aspirin; Bronchial asthma; Bronchial hyperreactivity; Lysine acetylsalicylate; Nonsteroidal antiinflammatory drugs

Indexed keywords

LYSINE ACETYLSALICYLATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030791933     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70197-0     Document Type: Article

References (42)

1. Djukanovitc R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
2. National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992;5:601-41.
3. The British Thoracic Society. Guidelines on management of asthma. Thorax 1993;48(suppl):S1-24.
4. Bianco S, Pieroni MG, Refini RM, Robuschi M, Vaghi A, Sestini P. Could NSAIDs have a role as antiasthmatic drugs? Drugs 1994;48:9-15.
5. Smith AP, Dunlop L. Prostaglandins and asthma. Lancet 1975;1:39.
6. Fairfax AJ, Hanson JM, Morley J. The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol 1983;52:393-8.
7. Joubert JR, Shepard E, Mouton W, Van Zyl L, Viljoen I. Nonsteroid anti-inflammatory drugs in asthma: Dangerous or useful therapy? Allergy 1984;40:202-7.
8. Kirby JG, Hargreave FE, Cockroft DW, O'Byrne PH. Effect of indomethacin on allergen-induced asthmatic response. J Appl Physiol 1989;66:578-83.
9. Fish JE, Ankin MG, Adkinson NF Jr, Peterman IV. Indomethacin modification of immediate immunologic airway responses in allergic asthmatic and nonasthmatic subjects. Evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis 1981;123:609-14.
10. Shepard ED, Malan L, MacFarlane CN, Monton W, Jaubert JR. Lung function and plasma levels of thromboxane B2, 6.ketoprostaglandin F1-alpha and beta2-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. Br J Clin Pharmacol 1985;19:459-70.
11. Sladeck K, Dworsky R, Fitzgerald GA, et al. Allergen stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis 1990;141:1441-5.
12. Curzen R, Rafferty P, Holgate ST. Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. Thorax 1987;42:946-52.
13. Hamid H, Rafferty P, Holgate ST. The inhibitory effect of terfenadine and flurbiprofen on early and late phase bronchoconstriction following allergen challenge in atopic asthma. Clin Exp Allergy 1990;20:261-7.
14. Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Sestini P. Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water. J Allergy Clin Immunol 1992;90:833-9.
15. Bianco S, Robuschi M, Simone P. Aspirin induced tolerance in aspirin asthma detected by a new challenge test. IRCS J Med Sci 1977;5:129.
16. Sestini P, Pieroni MG, Refini RM, et al. Time-limited protective effect of inhaled furosemide against aspirin-induced bronchoconstriction in aspirin sensitive asthmatics. Eur Respir J 1994;7:1825-9.
17. Bianco S, Pieroni M, Refini R, Rottoli L, Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med 1989;321:1069-73.
18. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University Press, 1980.
19. McLean JA, Bacon JR, Mathews KP, Banas J, Capati D, Bayne NK. Effect of aspirin on nasal responses in atopic subjects. J Allergy Clin Immunol 1983;72:187-92.
20. Ciprandi G, Buscaglia S, Cerqueti PM, Canonica GW. Drug treatment of allergic conjunctivitis. A review of evidence. Drugs 1992;43:154-76.
21. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs. Differences and similarities. N Engl J Med 1991;324:1716-25.
22. Dahl R, Johansson SA. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis [Suppl] 1982;63:167-75.
23. Spector SL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy Asthma Immunol 1995;75:463-74.
24. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987;136:740-51.
25. Diaz P, Conzales MC, Galleguillos FR, et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989;139:1383-9.
26. Brusasco V, Crimi E, Gianorio P, Lantero S, Rossi GA. Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol 1990;69:2209-14.
27. Noguchi K, Ishikawa K, Yano M, Ahmed A, Cortes A, Abraham WM. Endothelin-1 contributes to antigen-induced airway hyperresponsiveness. J Appl Physiol 1995;79:700-5.
28. Payne AN, Whittle BJR. Potent cyclooxygenase-mediated bronchoconstrictor effects of endothelin in the guinea pig in vivo. Eur J Pharmacol 1988;233:303-4.
29. Vaghi A, Pieroni MG, Robuschi M, et al. Inhaled lysine acetylsalicylate does not prevent methacholine-induced bronchospasm. Eur Respir J 1991;4:235s.
30. Isel PA. Analgesic-antipyretics and antiinflammatory agents. In: Goodman Gilman A, Rail TW, Nies AS, Taylor P, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1991. p. 638-70.
31. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995;44:1-10.
32. Toivanen J, Ylikorkala O, Viinikka L. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphopyrazone, acetyl-salicylic acid and indomethacin by human tissues in vitro. J Thromb Res 1985;37:493-502.
33. Littner MR, Kazmi GT, Lott FD. Distribution of cyclooxygenase inhibition in isolated dog lung. J Appl Physiol 1986;1:988-3.
34. Pasargiklian M, Bianco S, Allegra L, et al. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 1977;34:79-91.
35. Pavord ID, Wong CS, Williams J, Tattersfield AE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1992;148:87-90.
36. Adams GK, Lichtenstein LM. Indomethacin enhances the response of human bronchus to antigen. Am Rev Respir Dis 1985;131:8-10.
37. Sestini P, Refini RM, Bucalossi A, et al. Effect of inhaled nonsteroidal anti-inflammatory drugs on blood plateled aggregation [abstract]. Am J Respir Crit Care Med 1995;151:387.
38. Abramson SB, Weissmann G. The mechanism of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989;32:1-9.
39. Bomalaski JS, Hirata F, Clark MA. Aspirin inhibits phospholipase C. Biochem Biophys Res Commun 1986;139:115-21.
40. Weber C, Erl W, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995;91:1914-7.
41. Bianco S, Vaghi A, Robuschi M, Pieroni MG, Refini RM, Sestini P. Steroid-sparing effect of inhaled lysine-aspirin and furosemide in steroid-dependent asthma. In: Melillo G, O'Byrne PH, Marone G, editors. Respiratory allergy. Amsterdam: Elsevier, 1993; p. 261-9.
42. Bianco S, Vaghi A, Robuschi M, Refini RM, Pieroni MG, Sestini P. Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose bechlomethasone-dependent asthma. J Allergy Clin Immunol 1995;95:937-43.